CA
VERA icon

Clearstead Advisors’s Vera Therapeutics VERA Stock Holding History

Clearstead Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86 Buy
+2
New +$75 ﹤0.01% 3391

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Clearstead Advisors's VERA Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Vera Therapeutics (VERA) in Q2 2026: 2 shares worth $86. The stake represents ﹤0.01% of the portfolio and ranks #3391 among its holdings.

56 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Clearstead Advisors held 2 shares of Vera Therapeutics worth $86 as of Q2 2026.
  • Vera Therapeutics was a new Clearstead Advisors position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3391 holding.
  • 56 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.